Table 5 Univariate analysis of FN and αvβ3 expression and osteosarcoma patient survival based on the log-rank test

 High

19

21.74

4.83

12.28–31.19

< 0.001

42.65

6.43

30.04–55.26

< 0.001

 Low/negative

41

61.08

5.19

50.91–71.25

75.16

3.75

67.81–82.52

 High

16

16.06

3.34

9.51–22.62

< 0.001

33.38

6.08

21.45–45.30

< 0.001

 Low/negative

44

61.41

4.96

51.69–71.13

77.30

3.31

70.80–83.79

FN⁺/αvβ3⁺

10

15.10

2.90

9.42–20.78

< 0.001

24.10

3.22

17.80–30.41

< 0.001

 vs. others^a

50

55.60

4.91

45.98–65.22

73.31

3.61

66.23–80.39

FN⁺/αvβ3⁺

10

15.10

2.90

9.42–20.78

< 0.001^b

0.177^c

24.10

3.22

17.80–30.41

< 0.001^b

0.005^c

FN⁺/αvβ3⁻ plus FN⁻/αvβ3⁺

15

27.60

6.75

14.36–40.84

< 0.001^b

58.57

7.41

44.06–73.09

0.022^b

FN⁻/αvβ3⁻

35

67.14

5.09

57.16–77.13

78.43

3.57

71.43–85.43